Markets:

Overview

News

Currencies

International

Treasuries

Galapagos NV - American Depositary Shares (NQ:GLPG)

33.52 -0.66 (-1.93%)

Streaming Delayed Price Updated: 10:15 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Galapagos NV - American Depositary Shares

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 27, 2022

Gainers Galapagos (NASDAQ:GLPG) stock rose 21.4% to $64.75 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.5 million, which is...

Via Benzinga

Mid-Day Market Update: Dow Jumps Over 500 Points; Seagate Shares Surge On Upbeat Results ↗

January 27, 2022

The Dow Jones extended gains, surging by more than 500 points. The country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3%...

Via Benzinga

Mid-Morning Market Update: US Markets Open Higher As GDP Rises 6.9% In Fourth Quarter ↗

January 27, 2022

US stocks opened on a strong note on Thursday after the country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 27, 2022

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4...

Via Benzinga

46 Stocks Moving In Thursday's Mid-Day Session ↗

January 27, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling...

Via Benzinga

The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study ↗

January 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 ↗

January 27, 2022

Upgrades

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 27, 2022

Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday!

Via InvestorPlace

26 Stocks Moving in Thursday's Pre-Market Session ↗

January 27, 2022

Gainers The National Security Group, Inc. (NASDAQ: NSEC) rose 63.7% to $15.10 in pre-market trading after VR Insurance Holdings announced acquisition of The National...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 26, 2022

Gainers Reneo Pharmaceuticals (NASDAQ:RPHM

Via Benzinga

The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data ↗

January 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces Positive FY21 Results Orphazyme A/S (NASDAQ: ORPH)...

Via Benzinga

recession in 2022? ↗

December 06, 2021

China has cut its reserve requirement for lending by 50% giving a $188 bn boost to its market.

Via Talk Markets

Topics Economy

Monday Market Coverage ↗

November 15, 2021

Gold is up today on inflation fears.

Via Talk Markets

Galapagos NV (GLPG) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

GLPG earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients ↗

October 05, 2021

Galapagos NV (NASDAQ: GLPG) announced results of two post-hoc analyses from the SELECTION and SELECTION LTE studies of filgotinib for active ulcerative colitis (UC...

Via Benzinga

Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease ↗

October 04, 2021

Galapagos NV (NASDAQ: GLPG) has randomized the last patient into the DIVERSITY Phase 3 study of filgotinib in the induction and maintenance of remission in...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 31, 2021

Gainers Sonnet BioTherapeutics (NASDAQ:SONN

Via Benzinga

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗

September 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Galapagos' Long-Serving CEO Onno Van De Stolpe To Exit After R&D Setbacks ↗

August 31, 2021

After 22 years at the helm of Galapagos NV (NASDAQ: GLPG), chief executive Onno van de Stolpe has decided it is time to retire and hand the reins to new...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021 ↗

August 19, 2021

Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Galapagos NV (GLPG) Q2 2021 Earnings Call Transcript ↗

August 07, 2021

GLPG earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Galapagos NV - American Depositary Shares (NQ:GLPG)

All News about Galapagos NV - American Depositary Shares

Starting at $3.75/week.

Subscribe Today